Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.

Kajihara H, Yamada Y, Shigetomi H, Higashiura Y, Kobayashi H.

Int J Gynecol Pathol. 2012 Jul;31(4):304-12. doi: 10.1097/PGP.0b013e318243a97b.

PMID:
22653342
2.
3.

Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.

Kao YC, Lin MC, Lin WC, Jeng YM, Mao TL.

Histopathology. 2012 Nov;61(5):760-8. doi: 10.1111/j.1365-2559.2012.04267.x. Epub 2012 Jul 2.

PMID:
22747504
4.

Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.

Higashiguchi A, Yamada T, Susumu N, Mori T, Suzuki A, Aoki D, Sakamoto M.

Cancer Sci. 2007 Mar;98(3):387-91.

5.

Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.

Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH.

Histopathology. 2014 Mar;64(4):585-96. doi: 10.1111/his.12286. Epub 2013 Dec 7.

PMID:
24103020
6.

Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.

Yamamoto S, Tsuda H, Aida S, Shimazaki H, Tamai S, Matsubara O.

Hum Pathol. 2007 Jul;38(7):1074-80. Epub 2007 Apr 18.

PMID:
17442376
7.

Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.

Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T.

Cancer. 2002 Jun 1;94(11):2935-40.

9.

Histologic transformation of benign endometriosis to early epithelial ovarian cancer.

Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF Jr, Nikrui N, Goff BA.

Gynecol Oncol. 1996 Feb;60(2):238-44.

PMID:
8631545
10.

Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.

Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB.

Hum Pathol. 2011 Nov;42(11):1613-9. doi: 10.1016/j.humpath.2011.01.007. Epub 2011 Apr 14.

PMID:
21496868
11.

Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.

Kato N, Toukairin M, Asanuma I, Motoyama T.

Diagn Cytopathol. 2007 Apr;35(4):193-7.

PMID:
17351940
12.

A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.

Chew S, Tham KF, Ratnam SS.

Singapore Med J. 1997 Jul;38(7):289-91.

PMID:
9339094
13.

Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.

Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I.

Cancer Lett. 2011 Nov 28;310(2):129-33. doi: 10.1016/j.canlet.2011.06.039. Epub 2011 Jul 8. Review.

PMID:
21802200
14.

The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.

Huang W, Cheng X, Ji J, Zhang J, Li Q.

Int J Gynecol Pathol. 2016 Jan;35(1):66-71. doi: 10.1097/PGP.0000000000000213.

PMID:
26166716
15.

Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.

Li Q, Zeng X, Cheng X, Zhang J, Ji J, Wang J, Xiong K, Qi Q, Huang W.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8305-10. eCollection 2015.

17.

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

McCluggage WG.

Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Review.

PMID:
21716157
18.

Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.

Silva EG, Young RH.

Am J Surg Pathol. 2007 Aug;31(8):1203-8. Erratum in: Am J Surg Pathol. 2007 Oct;31(10):1628.

PMID:
17667544
19.

Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.

Cuff J, Longacre TA.

Am J Surg Pathol. 2012 May;36(5):688-95. doi: 10.1097/PAS.0b013e31824b6eed.

PMID:
22498820
20.

Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).

Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H, Kobayashi H.

Oncol Rep. 2010 May;23(5):1193-203. Review.

PMID:
20372830

Supplemental Content

Support Center